Latest News-Samsung Biologics Co. Ltd. Mediaroom_Page

Samsung Biologics holds 11th Annual General Meeting of Shareholders

INCHEON, South Korea, March 28, 2022 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), the world'...

2022-03-29 09:42 1757

Samsung Biologics holds 11th Annual General Meeting of Shareholders

Samsung Biologics receives 2022 CMO Leadership Award in all six categories

INCHEON, South Korea, Feb. 7, 2022 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), the world's ...

2022-02-07 20:00 1756

Samsung Biologics receives 2022 CMO Leadership Award in all six categories

Samsung Biologics reaches agreement with Biogen to acquire full ownership of Samsung Bioepis

* Agreement with Biogen to buyout Biogen's (50% -1 share) stake in Samsung Bioepis Joint Venture ...

2022-01-28 08:10 1645

Samsung Biologics Reports Fourth Quarter & Fiscal Year 2021 Financial Results

* Q4'21 revenue of KRW 444.3 billion increased 18% compared to Q4'20. * Q4'21 operating profit o...

2022-01-24 16:25 1739

Samsung Biologics Shares Strategic Roadmap for Sustainable Growth at the 40th Annual JP Morgan Healthcare Conference

INCHEON, South Korea, Jan. 12, 2022 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced it...

2022-01-13 08:52 1721

Moderna COVID-19 Vaccine Manufactured in Korea by Samsung Biologics Receives Marketing Authorization from Ministry of Food and Drug Safety of Korea

CAMBRIDGE, Mass. and INCHEON, South Korea, Dec. 14, 2021 /PRNewswire/ -- Moderna (Nasdaq: MRNA), a ...

2021-12-14 13:34 1370

Moderna COVID-19 Vaccine Manufactured in Korea by Samsung Biologics Receives Marketing Authorization from Ministry of Food and Drug Safety of Korea

Samsung Biologics and AstraZeneca expand strategic manufacturing partnership to include COVID-19 and cancer therapy

INCHEON, South Korea, Dec. 13, 2021 /PRNewswire/ -- Samsung Biologics (207940.KS), the world's lead...

2021-12-14 08:55 1457

Samsung Biologics and AstraZeneca expand strategic manufacturing partnership to include COVID-19 and cancer therapy

Samsung Biologics adds to global ISO certifications with Quality Management System

* Samsung Biologics earns ISO9001 for Quality Management System, proving its capabilities to ensu...

2021-12-07 13:04 1414

Samsung Biologics adds to global ISO certifications with Quality Management System

GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing

BOSTON and INCHEON, South Korea, Nov. 24, 2021 /PRNewswire/ -- GreenLight Biosciences (Nasdaq: ENVI...

2021-11-24 20:00 1698

GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing

Samsung Biologics Reports Third Quarter 2021 Financial Results

* Q3'21 revenue of KRW 450.7 billion increased 64% compared to Q3'20. * Q3'21 operating profit o...

2021-10-26 15:23 1474

Samsung Biologics Reports Third Quarter 2021 Financial Results

Samsung Biologics showcases its newest CDO process platform, S-Cellerate™, at BPI 2021, offering expedited timeline to IND and BLA

INCHEON, South Korea, Sept. 22, 2021 /PRNewswire/ -- Samsung Biologics, a global contract developme...

2021-09-22 18:00 1252

Samsung Biologics showcases its newest CDO process platform, S-Cellerate™, at BPI 2021, offering expedited timeline to IND and BLA

Samsung Biologics Joins Frontier 1.5D Project as part of 2050 Carbon Neutral Initiative

INCHEON, South Korea, Sept. 13, 2021 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), the world'...

2021-09-13 12:41 1293

Samsung Biologics Joins Frontier 1.5D Project as part of 2050 Carbon Neutral Initiative

Kineta and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-VISTA Antibody Immunotherapy

* Kineta to leverage Samsung Biologics' development and manufacturing expertise to advance KVA12....

2021-07-20 20:00 1207

Kineta and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-VISTA Antibody Immunotherapy

Samsung Biologics Issues Its First Annual Sustainability Report

* Consolidation of the company's roadmap to creating an improved business environment * Establi...

2021-06-25 09:01 22326

Samsung Biologics Issues Its First Annual Sustainability Report

Over a year into the global pandemic, Samsung Biologics continues to leverage innovative virtual platform for remote audits and regulatory inspections

* Samsung Biologics' Live Virtual Tour (LVT) used in one of the earliest FDA full virtual assessm...

2021-06-23 19:28 1185

Over a year into the global pandemic, Samsung Biologics continues to leverage innovative virtual platform for remote audits and regulatory inspections

Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate

INCHEON, South Korea, June 2, 2021 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), the world's ...

2021-06-02 19:00 1154

Latest News